August 9, 2022 | |
Company: | FINDEX Inc |
Representative: | Teruo Aibara, President & CEO |
(Stock code: 3649, TSE Prime) | |
Contact: | Atsushi Fujita |
Director and Head of Administration | |
(TEL: +81-89-947-3388) |
[Correction] Notice of partial corrections
to the Consolidated Financial Results [Japanese GAAP]
for the First Quarter of the Fiscal Year Ending December 31, 2022
We have found that corrections are required to certain items stated in the Consolidated Financial Results [Japanese GAAP] for the First Quarter of the Fiscal Year Ending December 31, 2022, which was disclosed on May 12th, 2022. The followings below are details of corrections.
1. Reason for corrections
After having filed the Consolidated Financial Results [Japanese GAAP] for the First Quarter of the Fiscal Year Ending December 31, 2022, we discovered partial error in stated items. This notice is retrospectively to correct those items.
2. Items to be corrected
Items to be retrospectively corrected are underlined as below.
[Before correction]
2. Quarterly Financial Statements and Notes
-
Notes to Quarterly Consolidated Financial Statement (Revenue Recognition)
The Group's revenues are primarily derived from revenues recognized from contracts with customers, and the following information breaks down the Group's reportable segments by the timing of revenue recognition and types of services.
FY 2022 1Q (From January 1, 2022, to March 31, 2022)
（JPY in Thousands）
Reportable segment | Total | |||
System development | Healthtech | |||
Timing of revenue recognition | ||||
Revenue recognized at a point | 861,224 | 43,397 | 904,622 | |
in time | ||||
Revenue recognized over | a | 359,953 | - | 359,953 |
period of time | ||||
Total | 1,221,178 | 43,397 | 1,264,576 | |
[After correction]
2. Quarterly Financial Statements and Notes
- Notes to Quarterly Consolidated Financial Statement
(Revenue Recognition)
The Group's revenues are primarily derived from revenues recognized from contracts with customers, and the following information breaks down the Group's reportable segments by the timing of revenue recognition and types of services.
FY 2022 1Q (From January 1, 2022, to March 31, 2022)
（JPY in Thousands）
Reportable segment | Total | |||
System development | Healthtech | |||
Timing of revenue recognition | ||||
Revenue recognized at a point | 598,682 | 43,397 | 642,080 | |
in time | ||||
Revenue recognized over | a | 622,495 | - | 622,495 |
period of time | ||||
Total | 1,221,178 | 43,397 | 1,264,576 | |